Accéder au contenu
Merck

PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling.

Communications biology (2020-10-25)
Mathilde Poulet, Jacinthe Sirois, Kevin Boyé, Noriko Uetani, Serge Hardy, Thomas Daubon, Alexandre Dubrac, Michel L Tremblay, Andreas Bikfalvi
RÉSUMÉ

Protein tyrosine phosphatases are essential modulators of angiogenesis and have been identified as novel therapeutic targets in cancer and anti-angiogenesis. The roles of atypical Phosphatase of Regenerative Liver (PRL) phosphatases in this context remain poorly understood. Here, we investigate the biological function of PRL phosphatases in developmental angiogenesis in the postnatal mouse retina and in cell culture. We show that endothelial cells in the retina express PRL-2 encoded by the Ptp4a2 gene, and that inducible endothelial and global Ptp4a2 mutant mice exhibit defective retinal vascular outgrowth, arteriovenous differentiation, and sprouting angiogenesis. Mechanistically, PTP4A2 deletion limits angiogenesis by inhibiting endothelial cell migration and the VEGF-A, DLL-4/NOTCH-1 signaling pathway. This study reveals the importance of PRL-2 as a modulator of vascular development.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Tamoxifène, ≥99%
Sigma-Aldrich
Anticorps monoclonal de souris anti-α-actine de muscle lisse-Cy3, clone 1A4, purified from hybridoma cell culture
Sigma-Aldrich
Anti--actine antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-PRL-2 Antibody, clone 42, clone 42, from mouse